SEP 11, 2018 09:42 PM PDT

Widely-Used Drug Contributed To Skin Cancer

WRITTEN BY: Nouran Amin

Credit:  MIT

In a research study at the University of Dundee, Queen Mary University of London and the Wellcome Sanger Institute, a drug, by the name of azathioprine, which is used to treat inflammatory bowel disease (IBD), arthritis and vasculitis as well as preventing organ rejection in transplant patients, has been identified as a contributor the development of skin cancer.

Published in Nature Communications, the research identified a `strong case for an association' between azathioprine and a mutation found in a common form of skin cancer known as cutaneous squamous cell carcinoma (cSCC). Previously, it was known that azathioprine leads to a heightened photosensitivity to UVA light. Such sensitivity is believed to be the key behind its contribution to skin cancers. The study found that the use of azathioprine leaves a ‘molecular fingerprint’ in skin cancers, implicating it in cSCC. "We recommend all physicians give appropriate advice on UVA avoidance including year-round sun protection for their patients on azathioprine,” explains Professor of Dermatology--Charlotte Proby in the School of Medicine at Dundee.

Credit: Ctdermgroup.com

However, the research team is not necessarily promoting the withdrawal of azathioprine. "As with all medications the risks must be balanced against the benefits, particularly with the need to treat potentially life-threatening diseases with an effective drug," explains Proby. “It is important that sun protection, skin surveillance and early diagnosis/lesion removal are part of the routine management of patients on azathioprine."

cSCC is a commonly diagnosed skin cancer. "It's important to protect your skin from the sun when it's strong, especially if you burn easily or are taking medications which make you more sun-sensitive. The most effective protection is to spend time in the shade and cover up with a hat, long-sleeved top, and sunglasses. For the bits you can't cover, use sunscreen with at least 4 stars and SPF 15 or higher for protection against both UVA and UVB rays,” says Sarah Lowes of Cancer Research UK.

The research also revealed the molecular nature of cSCC which highlighted the potential targets that may be developed for future treatments.

Source: University of Dundee, Nature Communications

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUL 17, 2018
Drug Discovery
JUL 17, 2018
Hunger Hormones for Addiction Treatment?
Hunger hormones, or gut hormones, work to signal the body's state of hunger and fullness. These hormones could potentially serve as a key new treatment...
AUG 25, 2018
Videos
AUG 25, 2018
Engineering Targeted Nanoparticles
The Koch Institute at MIT has chosen one of Jason Chang's images as an Image Award recipient for 2018....
AUG 28, 2018
Drug Discovery
AUG 28, 2018
Drug Reduced Recurrent Ventricular Tachycardia
A common drug used to treat chest pain, known as ranolazine and branded as Ranexa®, was found to be safe in a clinical study of more than 1,000 patient...
SEP 08, 2018
Drug Discovery
SEP 08, 2018
Protein Associated With ALS Inspires Drug Treatments
Neurodegenerative diseases, such as degenerative ataxia or amyotrophic lateral sclerosis (ALS), will progressively cause an affected individual to develop ...
OCT 16, 2018
Neuroscience
OCT 16, 2018
Your brain tells if a placebo can treat pain
Placebo effect and predicting when a particular subject will have a placebo response by using as little as psychological questionnaires....
NOV 05, 2018
Microbiology
NOV 05, 2018
Potential Antidote to Botulism is Found
A microbe called Clostridium botulinum and sometimes two other strains of Clostridium bacteria can make a toxic chemical called botulism....
Loading Comments...